MINIMUM INHIBITORY CONCENTRATION QUALITY-CONTROL GUIDELINES FOR BIAPENEM, DU-6859A, FK-037, LEVOFLOXACIN, GREPAFLOXACIN, AND CEFTIZOXIME WHEN USING VARIOUS NATIONAL COMMITTEE FOR CLINICAL LABORATORY STANDARDS SUSCEPTIBILITY TEST METHODS

Authors
BALE MJ JONES RN ERWIN ME MURRAY PR WASHINGTON JA GERLACH EH THORNSBERRY C HINDLER J DOERN GV
Citation
Mj. Bale et al., MINIMUM INHIBITORY CONCENTRATION QUALITY-CONTROL GUIDELINES FOR BIAPENEM, DU-6859A, FK-037, LEVOFLOXACIN, GREPAFLOXACIN, AND CEFTIZOXIME WHEN USING VARIOUS NATIONAL COMMITTEE FOR CLINICAL LABORATORY STANDARDS SUSCEPTIBILITY TEST METHODS, Diagnostic microbiology and infectious disease, 19(1), 1994, pp. 65-68
Citations number
9
Categorie Soggetti
Microbiology,"Infectious Diseases
Journal title
Diagnostic microbiology and infectious disease → ACNP
ISSN journal
07328893
Volume
19
Issue
1
Year of publication
1994
Pages
65 - 68
Database
ISI
SICI code
0732-8893(1994)19:1<65:MICQGF>2.0.ZU;2-4
Abstract
Several multilaboratory collaborative studies using broth microdilutio n and agar dilution (gonococcal tests only) methods of susceptibility testing were performed to establish quality-control (QC) guidelines. R eplicate dilution tests with multiple lots of media were performed wit h National Committee for Clinical Laboratory Standards recommended QC strains (Escherichia coli ATCC 25922, Pseudomonas aeruginosa ATCC 2785 3, Enterococcus faecalis ATCC 29212, and Staphylococcus aureus ATCC 29 213) by using the following antimicrobials: biapenem, DU-6859a, FK-037 , levofloxacin, and grepafloxacin. In addition QC MIC ranges, using ap propriate medium modification for Haemophilus influenzae ATCC 49247 an d Neisseria gonorrhoeae ATCC 49926 were reported on four (DU-6859a, FK -037, levofloxacin, and grepafloxacin) and two (ceftizoxime and FK-037 ) antimicrobials, respectively.